2016-03-07T00:00:00.000-05:00
NeuWave Medical,0.399605
transaction,-0.266911
Buy rating,0.213883
price target,0.416495
longer term outlook,0.581956
biosimilar delays,-0.360267
spine companies K2M,0.327811
Outperform rating,0.581956
Piper Jaffray analyst,0.441899
pharma unit,0.581956
newly launched Darzalex,0.359151
Globus Medical,0.205685
Brooks West,0.441899
definitive agreement,0.399605
trauma,-0.152587
Financial terms,-0.266911
firm,0.27615
Zytiga drugs,-0.355026
revenue growth,0.27615
key existing drugs,-0.355026
Remicade,-0.429293
shares,0.517801
Johnson,0.323373
AbbVie,0.213883
business restructuring,0.286086
Stryker,0.286086
upcoming generic competition,-0.355026
large joints,0.229109
medical device,0.287119
